Dec 20th, 2017. Sensorion, Cochlear to evaluate drug-implant combo in hearing loss.
By Cormac Sheridan and Tamra Sami. Buy a reprint to read.
Boursier.com : Interview of Nawal Ouzren, CEO Sensorion, Video (In French)
La Lettre M - Cochlear will invest around €1.6 million and receive an equity stake in Sensorion. Read (in French)
Sensorion strengthens its financial structure by issuing a €4.7 million nominal bond issue subscribed by new European investors and management. Bpifrance has selected Sensorion for its program "Hub Health Tech". Read
Sensorion to present new SENS-401 data at ARO 2019 MidWinter Meeting, Feb. 9-13, 2019. Read